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Background: Coats plus syndrome is an autosomal recessive, pleiotropic, multisystem disorder characterized by
retinal telangiectasia and exudates, intracranial calcification with leukoencephalopathy and brain cysts, osteopenia
with predisposition to fractures, bone marrow suppression, gastrointestinal bleeding and portal hypertension. It is
caused by compound heterozygous mutations in the CTC1 gene.
Case presentation: We encountered a case of an eight-year old boy from an Indian family with manifestations of
Coats plus syndrome along with an unusual occurrence of dextrocardia and situs inversus. Targeted resequencing
of the CTC1 gene as well as whole exome sequencing (WES) were conducted in this family to identify the causal
variations. The identified candidate variations were screened in ethnicity matched healthy controls. The effect of CTC1
variation on telomere length was assessed using Southern blot. A novel homozygous missense mutation c.1451A > C
(p.H484P) in exon 9 of the CTC1 gene and a rare 3′UTR known dbSNP variation (c.*556 T > C) in HES7 were identified as
the plausible candidates associated with this complex phenotype of Coats plus and dextrocardia. This CTC1 variation
was absent in the controls and we also observed a reduced telomere length in the affected individual’s DNA,
suggesting its likely pathogenic nature. The reported p.H484P mutation is located in the N-terminal 700 amino
acid regionthat is important for the binding of CTC1 to ssDNA through its two OB domains. WES data also showed a
rare homozygous missense variation in the TEK gene in the affected individual. Both HES7 and TEK are targets of the
Notch signaling pathway.
Conclusions: This is the first report of a genetically confirmed case of Coats plus syndrome from India. By means of
WES, the genetic variations in this family with unique and rare complex phenotype could be traced effectively. We
speculate the important role of Notch signaling in this complex phenotypic presentation of Coats plus syndrome and
dextrocardia. The present finding will be useful for genetic diagnosis and carrier detection in the family and for other
patients with similar disease manifestations.
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Mutations in the genes involved in the telomere length
maintenance complex have been reported to be associated
with a variety of clinically heterogeneous multisystem dis-
orders. This includes Cerebro-Retinal Microangiopathy
with Calcifications and Cysts (CRMCC)/Coats plus syn-
drome (CTC1 mutations), Dyskeratosis Congenita (DC/
nail dysplasia, skin pigmentation defects and oral leuko-
plakia; associated with mutations in DKC1, CTC1 and
seven other genes), and two other DC variant diseases,
Hoyeraal-Hreidarsson syndrome (bone-marrow failure,
intrauterine growth retardation, microcephaly, immuno-
deficiency and cerebellar atrophy; associated with RTEL1,
DKC1, TERT and TINF2 mutations) and Revesz syndrome
(aplastic anemia, retinopathy, intracranial calcifications
and cerebellar hypoplasia; associated with TINF2 muta-
tions) [1-3]. In all of these diseases, some features of DC
like sparse/gray hair, nail dystrophy and bone marrow
failure appear as the overlapping phenotype. In addition,
idiopathic pulmonary fibrosis, gastrointestinal bleeding,
skeletal deformities and predisposition to certain forms of
cancer have been described with some of the telomere
biology related genes like CTC1 [3]. Since its initial identi-
fication, more than 20 recessive mutations associated with
CRMCC/Coats plus syndrome and DC phenotype have
been described in the CTC1 gene [1,2,4,5]. In earlier litera-
ture on this disease CRMCC has been used as an umbrella
term to encompass two separate but similar diseases:
Coats Plus syndrome and LCC. However, after identifica-
tion of CTC1 mutation with Coats plus syndrome, the
two are considered non-allelic, genetically distinct disor-
ders and Coats plus is the appropriate term than CRMCC
to encompass Cerebroretinal microangiopathy lesions
with other non-neurological features [6]. Overall Coats
plus syndrome shows phenotypic overlap with Revesz syn-
drome (exudative retinopathy, intracranial calcification,
bone marrow failure and shortened telomeres) as well as
Labrune syndrome (LCC; leukoencephalopathy, intracra-
nial calcifications and cysts) [2,7]. In a few cases of Coats
plus, cardiac lesions and abnormalities like microangio-
pathy, atrial and ventricular septal defects have also been
reported [4].
Previously described CTC1 mutations have been found
to occur in a compound heterozygous state with one
protein truncating mutation always coupled to another
missense variant [2,4,5]. It has also been reported that
CTC1 variations that cause protein truncation effects
telomere length shortening more than the missense vari-
ation in cell line models, although conflicting results
have been observed in patient sample based telomere
length analysis [8].
We encountered a patient who manifested typical fea-
tures of Coats plus syndrome and showed an unusual
association of dextrocardia with situs inversus (reversedpattern of internal visceral organs on the left-right axis).
Initial screening for CTC1 mutations by targeted rese-
quencing identified a homozygous missense variation.
Owing to this being the first description of a homozygous
missense variant in CTC1 to occur along with Coats plus
and the presence of dextrocardia, we extended our search
for mutation(s) in other telomere biology and dextrocardia
related genes in this family using whole exome sequencing.
Case presentation
Clinical description
The propositus (II-1), an eight-year old boy of a non-
consanguineous parentage (Figure 1, i) with mildly delayed
developmental milestones, was referred to the National
Institute of Mental Health and Neuro Sciences, Bangalore,
for evaluation of gradually progressive left spastic hemi-
paresis of three months duration. At the age of 18 months,
his eyes manifested retinal telangiectasia and exudates
compatible with the diagnosis of the Coats Disease. He
had received laser photocoagulation in the right eye,
multiple sessions of injection of Avastin (Bevacizumab)
and vitreous lavage. On physical examination, his vitals
were stable. His neurological examination revealed mild
left facial weakness with spasticity in the left upper and
lower limb. His deep tendon reflexes were brisk bilaterally
(right more than the left). Among extra-neurological fea-
tures, he had convergent squint of right eye, premature
graying of hair, two café-au-lait spots over the forearm
(1×2 cm) and bilateral contracture of tendo Achilles (left
more than right). Ophthalmologic examination showed
absent perception of light on the right side with just
perception of hand movements in the left eye along with
corneal opacity; leukocoria in the right eye were also
noted (Figure 1, ii-A). A general radiological survey for
additional features by X-ray, echocardiogram and ultra-
sound of the chest showed evidence of dextrocardia with
situs-inversus (Figure 1, ii-B). The X-rays based skeletal
survey showed the presence of osteopenia with flaring of
the metaphysial region.
Further radiological evaluation of cranial cavity using
CT scan of the brain showed calcifications in bilateral
thalamus, right parieto-occipital and left parietal regions
(Figure 1, ii-C). Examination of the skull showed the
presence of intracranial calcifications (Figure 1, ii-D). MRI
(magnetic resonance imaging) of the brain revealed mixed
intensity solid cystic lesion in the bilateral thalami (T1W
image) (Figure 1, ii-E), T2 and flair hyperintensities involv-
ing bilateral frontal and parieto-occipital deep white
matter, brainstem and bilateral middle cerebral peduncle.
Several tiny cystic spaces were seen in the bilateral
parieto-occipital regions. The right ocular globe showed
evidence of retinal detachment (T2W) (Figure 1, ii-F-I).
SWI phase image showed hypointense signal intensity in
the areas of blooming consisted with the calcification
Figure 1 Coats plus syndrome phenotype and mutation analysis of the CTC1 and HES7 in the family. i) Pedigree diagram. ii-A) Photograph
showing greying of the hair, right corneal opacity and leukocoria. ii-B) X-ray chest showing the presence of dextrocardia. ii-C) CT scan of the brain
showing calcifications in bilateral thalamus, right parieto-occipital and left parietal regions. ii-D) An X-ray image of the lateral view of the skull showing
the presence of intracranial calcifications. ii-E) Brain-MRI:Axial T1W image showing mixed intensity solid cystic lesion in the bilateral thalami. ii-F) Axial
T2W image showing hyperintense lesion with few areas of T2 shortening and abundant perilesional edema. ii-G) Susceptibility weighted image
(SWI) showing abundant susceptibility within the lesion as well as in the rest of the neuroparenchyma. ii-H&I) Similar lesions noted in the pons
with abundant signal changes, susceptibility and edema. In addition, T2W axial image shows retinal detachment in the right eyeball. ii-J) SWI phase
image showing hypointense signal intensity in the areas of blooming, which suggests the presence of calcification within the lesion. iii) Sequencing
chromatograms from the affected individual (II-1) and both parents (I-1 and I-2). Note the nucleotide change A > C (arrow) in a homozygous state in
the affected individual II-1 and in a heterozygous state in both parents. DNA from the unaffected individual II-2 was not available for genetic analysis.
iv) Conservation of the H (histidine) residue across different species in the CTC1 protein. v) sequencing chromatogram of HES7 3′UTR variation
(T > C change, arrow marked) from affected individual (II-1), heterozygous parent(Mother) and a healthy control subject.
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deranged liver function indices with normal renal func-
tions and electrolytes levels were observed. Complete
blood cell counts showed mild leukopenia (total count =
3900 cells/cu mm) and thrombocytopenia (74,000 cells/cu
mm). He has been receiving anti-spastic medications and
physiotherapy for his motor illness. In summary, based on
the presence of intracranial calcifications, symmetrical
cystic lesions and clinical features of bilateral Coats dis-
ease of the eye (retinal telangiectasia and exudates) along
with other extra-neurological manifestations, he was diag-
nosed with Coats plus syndrome.Methods
This research followed the tenets of the Declaration of
Helsinki and the guidelines of the Indian Council of
Medical Research, New Delhi. Following informed con-
sent, peripheral blood DNA was extracted from the
proband (case:II-1) and both the parents using a com-
mercial kit, Wizard™ Genomic DNA Purification Kit
(Promega, Madison, WI).
Targeted resequencing of CTC1
The entire coding region and intron-exon junctions of
the CTC1 gene were amplified by polymerase chain
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Table S1). The amplified PCR products were subjected
to Sanger sequencing using ABIprism A370- sequencer
(ABI, Foster City).
Whole Exome Sequencing (WES)
Whole exome sequencing (WES) was carried out in
three members of this family comprising the proband
and both the parents. For exome sequencing, 2 μg of
DNA was used for fragmentation, and DNA library
preparation was carried out according to Illumina DNA
sample prep protocol.v2. Exonic regions were captured
and enriched using Truseq Illumina exome capture kit.
v2 protocol. Cluster generation using cBOT was carried
out for exome enriched libraries on Illumina flow cell.v3
followed by 100 bp paired end sequencing on Hiseq2000
using Illumina SBS kit.v3 protocol. Nearly 12 Gb raw
data were generated for each sample. The base calls for
all the sample reads were analyzed on CASAVA and
subsequent pipeline for data processing is described in
the following section. Whole exome sequencing analysis
was performed as described before [9] with slight modi-
fications at the level of raw read clipping (for details see
Additional file 1: Table S2 and Text). From WES data,
variation data (known and novel variations) for 15 candi-
date genes involved in telomere length maintenance
activity (TERF2IP, POT1, TERF1, OBFC1/STN1, CTC1,
TERT, DKC1, WRAP53, TINF2, TPP1, TERF2, TEN1,
TERC, NHP2 and NOP10) (Additional file 1: Table S3)
and 28 genes associated with dextrocardia/situs-inversus
phenotype were initially analyzed (Additional file 1:
Tables S4 and S5). Following candidate gene analysis,
the WES data was analyzed independently to obtain any
likely disease associated candidate variation. The variant
filtering protocol was performed essentially as described
earlier [9].
In short, total variations (passing quality filters)→ pro-
tein deleterious variations→Novel variants (absent
in dbSNP/TGP)→ homozygous/compound heterozygous
variations→ In silico predicted damaging variations.
Homozygosity mapping
The combined variant calling file (vcf ) of WES data of
all the samples was analyzed for homozygosity mapping
using the web based homozygosity mapper tool with
default settings (http://www.homozygositymapper.org/).
Southern blot based analysis of telomere length
9 μg of genomic DNA (for each sample) was subjected
to overnight digestion by RsaI/HinfI (2U each). Digested
DNA samples were run overnight at 50 V and transferred
to a Nylon membrane, after denaturation and neutral-
ization. The hybridization was done in Amersham Rapid
Hyb buffer at 50°C, using the radio-labelled probe(CCCTAA)4. Post hybridization washes were done at 50°C,
and the membrane was exposed to a Storage Phosphor
Screen for overnight [10]. Imaging was done at Biorad PMI.
The validation of selected CTC1 variant and 3′UTR
variation of HES7 was carried out by both Sanger se-
quencing using Big-Dye terminator sequencing kit and
SNaPshot reaction kit (single base extension) for geotyping
on 3130xl sequencer (ABI, Foster City) and was validated
in DNA samples from 391 (for CTC1) and 370 (for HES7)
healthy controls.
Results and discussions
Novel homozygous missense variation in CTC1 observed
through targeted resequencing
The proband described in this study has clinical mani-
festations which conform to the diagnostic criteria of
Coats plus syndrome such as bilateral exudative retinop-
athy, intracranial calcification and cystic lesions along
with non-neurological features like premature graying of
hair, café-au-lait spots, osteopenia and metaphysical flar-
ing. Neurologically, the patient only had spasticity and
left hemiparesis with no history of seizures, ataxia or
dystonia (the later features have been reported in previ-
ously described cases of Coats plus). The patient showed
an unusual feature of abnormal right-left patterning of
the internal organs demonstrated as dextrocardia with
situs inversus which has not previously been described
as a manifestation of Coats plus clinically. Based on
prominent clinical features of Coats plus in our patient
(II-1), we carried out a targeted search for CTC1 muta-
tions by sequencing of the exonic regions. This led us to
identify a novel homozygous DNA variation, c.1451A > C
(p.H484P) in exon 9 of the CTC1 gene (Figure 1, iii). As
expected, both his parents (I-1 and I-2) were heterozygous
for this change (Figure 1, iii). Although the parents were
nonconsanguineously married, Indian large ethnic popula-
tion groups are known to have endogamous marriage
patterns which may explain the observed homozygosity
of the CTC1 variation in this patient. To best of our
knowledge, this variation has not been reported as a
polymorphic locus or associated with disease in the
current literature. A synonymous variation has been de-
scribed at the same amino acid position (chr17:8138232
A > G; p.H484H) in the recently available dataset from
Exome Aggregation Consortium (ExAC), Cambridge, MA
(http://exac.broadinstitute.org). (It is one of the largest
databases and catalogues variations from 61,486 exome
data). In the literature to date, all the reported CTC1
mutations either with Coats plus syndrome or with DC
phenotype have been observed as compound heterozy-
gous changes comprising at least one protein truncating
mutation (frameshift or nonsense). In order to gather
further evidence to substantiate the sole pathogenicity
of the observed homozygous p.H484P change in CTC1 in
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situs inversus, we extended our search to identify other
genetic defects through WES.
Whole exome sequencing analysis showed additional rare
variations and a 3 Mb homozygous stretch containing
CTC1 (p.H484P) and a rare 3′UTR HES7 variation
Initial analysis of the WES data included a targeted
search for rare variations in candidate genes involved in
telomere length maintenance. This analysis was conducted
to rule out the involvement of any other genes related to
telomere biology in the pathogenesis of Coats plus. We
observed 23 variations (novel and known) in 9 genes in
the patient and his parents, but none segregated with
Coats plus using both homozygous and compound het-
erozygous recessive model except for the CTC1 p.H484P
variant identified using sanger sequencing (Additional file
1: Table S3).
Next, the variation analysis of 28 dextrocardia/situs-
inversus candidate genes identified 9 known 3′UTR vari-
ations in accordance with homozygous recessive disease
model in HES7, GATA4 and SMAD2 genes. None of the
variants identified fitted the compound heterozygous model
(Additional file 1: Table S5). Among all the identified
homozygous variations, a 3′UTR variation rs182882481
(c.*556 T > C, HES7) appeared to be relevant to the
dextrocardia phenotype due to the fact that mutations
in HES7 (Hairy and Enhancer of Split 7) have previously
been described as a cause of Spondylocostal Dysostosis
4 (SCDO4) with dextrocardia. Despite the fact that
rs182882481 is present on the dbSNP database, we
propose that this variation may be pathogenic since, the
reported minor allele frequency is 0.092% (2/2179) and
there are no homozygous genotypes reported on the
TGP (1000Genome project) database.
Following this targeted search, we analyzed all the
exonic variations obtained from our WES data in an
unbiased manner to identify potential deleterious varia-
tions that are likely to explain the complex Coats plus
syndrome phenotype with dextrocardia/situs inversus.
The variant filtering (as described above in the method-
ology section) finally yielded us the same p.H484P change
in CTC1 along with three other likely damaging variations
in TEK, PER1, and MUC17 (Table 1). The CHet analysis
showed variations in three genes (DNHD1, SIVA1 and
KMT2C) segregating with the disease status (Additional
file 1: Table S6). Based on the literature and functional
relevance of other variations identified from our WES
data, only p.H484P change in the CTC1 gene was suggest-
ive of likely candidate status for Coats plus syndrome
phenotype in this patient.
We anticipated a region of extended homozygosity
around p.H484P (CTC1) which could contain some
additional pathogenic variation. Homozygosity mappinganalysis identified a large homozygous stretch (~3 Mb)
on chr17 containing both CTC1 p.H484P and HES7
rs182882481 (Additional file 1: Table S7). This finding
provides a possible explanation for the unusual associ-
ation of Coats plus with dextrocardia.
The p.H484P (CTC1) change was absent in 740 chro-
mosomes and HES7 variation (rs182882481) showed a
frequency of 0.1% (1:782 chromosomes) from ethnicity
matched controls where one control subject harbored a
heterozygous genotype.
Plausible pathogenicity of p.H484P (CTC1) with Coats plus
syndrome
To elucidate the functional impact of the identified
missense CTC1 variation, we carried out Southern blot
analysis. The patient’s DNA showed a reduction in the
telomere length compared to that of his parents
(Figure 2).
Based on the following five criteria, we considered p.
H484P as a likely disease associated variation responsible
for Coats plus syndrome phenotype and for genetic diag-
nosis: 1) This variation segregated with the disease follow-
ing a recessive mode of inheritance. 2) Telomere length is
significantly reduced in the affected individual. 3) Histi-
dine residue is conserved across different CTC1 orthologs
(Figure 1, iv). 4) Insilico analysis predicted this mutation/
change to be of damaging nature (Polyphen-2, score of
0.998). 5) It is absent in the 370 ethnicity matched control
subjects that we have genotyped, dbSNP, 1000 Genome,
Exome Variant Server and ExAC database.
The causative gene CTC1 (conserved telomere main-
tenance component 1 [#MIM 613129] for Coats plus
syndrome was identified independently by Anderson
et al. and Polvi et al. [2,4]. CTC1, located on chromo-
some 17p13.1, contains 23 exons and codes for a 1,217
amino acid long protein (http://www.genome.ucsc.edu).
This protein interacts with STN1 (OBFC1/oligonucleo-
tide/oligosaccharide-binding fold containing 1 [#MIM
613128]) and TEN1 (telomerase capping complex sub-
unit homolog (S. cerevisiae) [#MIM 613130]) to form a
trimeric CST complex [11]. The CST complex, but not
its individual components, binds to single-stranded(ss)
DNA with high affinity in a sequence independent man-
ner. The complex associates constantly with a fraction of
telomeres, suggesting that it might be protecting telomeres
from lethal degradation [11]. CTC1 has two oligonucleo-
tide/oligosaccharide-binding(OB) folds in its N-terminal
half and a third OB fold near the C terminus; the former
mainly contributes to the DNA binding activity of CTC1 as
OB folds are typically found in proteins that bind to
ssDNA, whereas the C-terminal OB fold is responsible for
the CST complex formation through interaction with STN1
[11]. The p.H484P mutation reported in our patient is
located in the N-terminal 700 amino acid region which is
Table 1 Whole exome analysis of variation data with autosomal recessive homozygous model in this family with coats
plus syndrome and dextrocardia phenotype
II-1(proband) I-1(Father) I-2(Mother)
Number of variations called(Pass/total) 70060/78946
number of variations per subject 54353 53466 51118
Novel variations(not reported in dbSNP135,TGP) count Total(homo/het) 1696(128/1568) 1700(143/1557) 1530(115/1415)
Novel protein deleterious variations(homo/het) 370(20/350) 381(19/362) 360(345/15)
Autosomal recessive homozygous model filtered variations 7
SNV 5(CTC1,NKTR,PER1,TEK,ZBTB4)
ins/del 2(FAM157A,MUC17)
Deleterious variations after computational prediction 4
SNV CTC1(p.H484P),PER1(p.A772T),TEK(p.E103D)
ins/del MUC17(Q1903Hfs*13)
Putative variation explaining Coats plus phenotype c.1451A > C; p.H484P(CTC1)
SNV; single nucleotide variations.
Bold indicates candidate variation prioritized (after applying filtering strategy) after WES analysis associated with Coats plus syndrome.
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two OB domains [11]. We speculated that the p.H484P
mutation might induce conformation change in the CTC1
protein, thus reducing its binding to ssDNA and in turn,
compromising the structural integrity of the telomeres.
This was further corroborated by the shortened telomere
length in the affected subject (in line with the previous
reports of shortened telomeres in individuals with CTC1
mutations).
Molecular links of dextrocardia/situs-inversus phenotype
in Notch signaling target genes
We observed a novel homozygous genotype in the 3′UTR
of HES7. Missense mutations of HES7 have been reported
to cause Spondylocostal Dysostosis 4 (SCDO4) [12]. A
duplication mutation (c.400_409dupAAACCGCCCC) in
HES7 has been reported to cause dextrocardia with situs
inversus in three out of four individuals showing SCOD4
manifestations, suggesting an incomplete penetrance of
this left-right patterning defect [13]. In our patient, we did
not find any skeletal deformities (abnormal vertebral
segmentation, ribs fusions, shortened trunk etc.) that are
usually reported with SCOD4. The null HES7-mice show
disruption of anterior-posterior polarity but no disruption
of left-right patterning [13]. Unfortunately, we cannot
show direct functional consequence of rs182882481
homozygous variation on HES7, but we speculate the role
of this variation on HES7 mRNA stability and its effect on
subsequent downstream signaling pathway. It is known
that HES7 is a transcriptional repressor of LFNG (Lunatic
Fringe) and an autorepressor. LFNG also regulates Notch
signaling through a feedback loop [14]. Their cyclic gene
expression plays an important role in the segmentation of
the presomitic mesoderm (PSM) and 3′UTRs of both the
genes are critical determinants of cyclical pattern of theirexpression by controlling mRNA stability [14]. Both the
genes are activated by Notch signaling and Notch signal-
ing plays an important role in the left-right pattern deter-
mination during embryogenesis and periodic somatic
segmentation [15,16].
We also observed a missense homozygous variation
(p.E103D) in TEK gene (Tyrosine kinase, endothelial)
(Table 1) which is also a target of Notch signaling.
However, we found the same TEK variation in a hetero-
zygous state in one healthy control subject from our in-
house generated whole exome data set (35 ethnicity
matched controls) and it has also been reported as a
very rare variation (0.08948%) in ExAC database. TEK,
a receptor protein with its ligand ANGPT1, promotes
vasculogenesis through Notch signaling [17]. Missense
mutations in TEK have been reported to cause cutaneo-
mucosal venous malformation (VMCM), which follow
an autosomal dominant mode of inheritance. Some
patients with TEK mutation manifest ventricular septal
defect, suggesting its role in cardiac development. How-
ever, direct role of TEK has not been implicated with
either Coats plus syndrome or dextrocardia phenotype till
date. Notch signaling regulates cardiac development,
septal development and coronary vascular development
[18]. Cardiac septal abnormalities, like atrial septal defect,
ventricular septal defect and coronary artery fistula have
been reported in a few cases of Coats plus syndrome
harboring compound heterozygous mutations in CTC1
[4]. This may also be suggestive of the role of CTC1 in
Notch signaling. Therefore, it is possible that the overall
complex association of Coats plus syndrome and dextro-
cardia/situs-inversus might be the resultof multiple gen-
etic factors comprising CTC1, HES7 and TEK and their
cross talk through Notch signaling deregulation. However,
it is very well possible that the p.H484P change of CTC1
Figure 2 Southern blot analysis to show the shortening of
telomere length in the affected individual. The telomere length
in father and mother is 10 Kb, whereas it is 8 Kb in the affected
individual. The telomere length was measured by the Bio-rad
Software One Density Plot. The asterisk shows internal TTAGGG
repeats, as a loading control.
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patient.
Conclusions
This is the first study to report a genetically confirmed
case of Coats plus syndrome from India. It also reports
the association of a homozygous CTC1 missense mutation
p.H484P with Coats plus syndrome. The genetic analysis
using WES in this family facilitated the identification aswell as establishment of the putative role of genetic varia-
tions for such a complex phenotype. The present finding
will be useful for genetic diagnosis and carrier detection in
the family and for other patients with similar disease
manifestations.
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